2023 대한갑상선학회 임신 중 및 산후 갑상선질환의 진단 및 치료 권고안 개정안

키워드

참고문헌 (321)

1. Glinoer D, "The regulation of thyroid function in pregnancy : pathways of endocrine adaptation from physiology to pathology", Endocr Rev, 18(3), pp.404~433 (1997)
2. Azizi F, "Treatment of post-partum thyrotoxicosis", J Endocrinol Invest, 29(3), pp.244~247 (2006)
3. Stagnaro-Green A, "Postpartum thyroiditis", Best Pract Res Clin Endocrinol Metab, 18(2), pp.303~316 (2004)
4. Weeke J, "A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy", Acta Endocrinol(Copenh), 101(4), pp.531~537 (1982)
5. Baloch Z, "Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease", Thyroid, 13(1), pp.3~126 (2003)
6. Soldin OP, "Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation : trends and associations across trimesters in iodine sufficiency", Thyroid, 14(12), pp.1084~1090 (2004)
7. Kahric-Janicic N, "Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy", Thyroid, 17(4), pp.303~311 (2007)
8. Sapin R, "Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy", Clin Lab, 50(9-10), pp.581~584 (2004)
9. Stricker R, "Evaluation of maternal thyroid function during pregnancy : the importance of using gestational agespecific reference intervals", Eur J Endocrinol, 157(4), pp.509~514 (2007)
10. Bocos-Terraz JP, "Thyroid hormones according to gestational age in pregnant Spanish women", BMC Res Notes, 2, pp.237~ (2009)
11. Derakhshan A, "Reference ranges and determinants of thyroid function during early pregnancy : the SELMA study", J Clin Endocrinol Metab, 103(9), pp.3548~3556 (2018)
12. Ollero MD, "Thyroid function reference values in healthy iodinesufficient pregnant women and influence of thyroid nodules on thyrotropin and free thyroxine values", Thyroid, 29(3), pp.421~429 (2019)
13. Huang C, "Establishment of assay method-and trimester-specific reference intervals for thyroid hormones during pregnancy in Chengdu, China", J Clin Lab Anal, 35(5), pp.e23763~ (2021)
14. Andersen SL, "Pregnancy week-specific reference ranges for thyrotropin and free thyroxine in the North Denmark region pregnancy cohort", Thyroid, 29(3), pp.430~438 (2019)
15. 최형욱, "한국여성에서 임신 초기 갑상선기능의 평가", International Journal of Thyroidology, 10(1), pp.36~41 (2017), 대한갑상선학회
16. Hye Jeong Kim, "Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area", The Korean Journal of Internal Medicine, 33(3), pp.552~560 (2018), 대한내과학회[DOI]
17. Dashe JS, "Thyroid-stimulating hormone in singleton and twin pregnancy : importance of gestational age-specific reference ranges", Obstet Gynecol, 106(4), pp.753~757 (2005)
18. 이가희, "임신 산후 갑상선질환의 진단 치료 권고안", International Journal of Thyroidology, 7(1), pp.7~39 (2014), 대한갑상선학회
19. Lambert-Messerlian G, "First-and secondtrimester thyroid hormone reference data in pregnant women : a FaSTER(First-and Second-Trimester Evaluation of Risk for aneuploidy)research consortium study", Am J Obstet Gynecol, 199(1), pp.62 e1~62 e6 (2008)
20. Mannisto T, "Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population", Thyroid, 21(3), pp.291~298 (2011)
21. Medici M, "Maternal early pregnancy and newborn thyroid hormone parameters : the generation R study", J Clin Endocrinol Metab, 97(2), pp.646~652 (2012)
22. Bestwick JP, "Thyroid stimulating hormone and free thyroxine in pregnancy : expressing concentrations as multiples of the median(MoMs)", Clin Chim Acta, 430, pp.33~37 (2014)
23. Li C, "Assessment of thyroid function during first-trimester pregnancy : what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?", J Clin Endocrinol Metab, 99(1), pp.73~79 (2014)
24. Carty DM, "Thyroid stimulating hormone(TSH)＞", =2. 5mU, Eur J Obstet Gynecol Reprod Biol, pp.2017, 210[DOI]
25. Han SM, "Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women", Clin Chem Lab Med, 51(12), pp.2295~2301 (2013)
26. 문희원, "Establishment of Trimester-Specific Reference Intervals for Thyroid Hormones in Korean Pregnant Women", Annals of Laboratory Medicine, 35(2), pp.198~204 (2015), 대한진단검사의학회
27. Maraka S, "Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment", BMJ, 356, pp.i6865~ (2017)
28. Nazarpour S, "Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies", J Clin Endocrinol Metab, 103(3), pp.926~935 (2018)
29. Toft AD, "Werner & Ingbar's the thyroid: a fundamental and clinical text", pp.329~344 (2005), Lippincott, Williams & Wilkins
30. Anckaert E, "FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC", tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations, 2010, pp.411(17-18), 1348~1353
31. Lee RH, "Free T4 immunoassays are flawed during pregnancy", Am J Obstet Gynecol, 200(3), pp.260 e1~260 e6 (2009)
32. Stockigt J, "Assessment of thyroid function : towards an integrated laboratory--clinical approach", Clin Biochem Rev, 24(4), pp.109~122 (2003)
33. Thienpont LM, "Report of the IFCC Working Group for standardization of thyroid function tests; part 2 : free thyroxine and free triiodothyronine", Clin Chem, 56(6), pp.912~920 (2010)
34. Moreno-Reyes R, "High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country : a population-based study", J Clin Endocrinol Metab, 98(9), pp.3694~3701 (2013)
35. Ashoor G, "Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia", Prenat Diagn, 30(11), pp.1032~1038 (2010)
36. Benhadi N, "Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy", Clin Endocrinol(Oxf), 66(6), pp.765~770 (2007)
37. La'ulu SL, "Second-trimester reference intervals for thyroid tests : the role of ethnicity", Clin Chem, 53(9), pp.1658~1664 (2007)
38. Abbassi-Ghanavati M, "Pregnancy outcomes in women with thyroid peroxidase antibodies", Obstet Gynecol, 116(2 Pt 1), pp.381~386 (2010)
39. Wasserman EE, "Maternal thyroid autoantibodies during the third trimester and hearing deficits in children : an epidemiologic assessment", Am J Epidemiol, 167(6), pp.701~710 (2008)
40. Pearce EN, "Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use", Endocr Pract, 14(1), pp.33~39 (2008)
41. Moleti M, "Gestational thyroid function abnormalities in conditions of mild iodine deficiency : early screening versus continuous monitoring of maternal thyroid status", Eur J Endocrinol, 160(4), pp.611~617 (2009)
42. McElduff A, "Thyroid function tests and thyroid autoantibodies in an unselected population of women undergoing first trimester screening for aneuploidy", Aust N Z J Obstet Gynaecol, 48(5), pp.478~480 (2008)
43. Unuane D, "Thyroglobulin autoantibodies : is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment?", Thyroid, 23(8), pp.1022~1028 (2013)
44. Glinoer D, "Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders", J Clin Endocrinol Metab, 79(1), pp.197~204 (1994)
45. Negro R, "Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease : effects on obstetrical complications", J Clin Endocrinol Metab, 91(7), pp.2587~2591 (2006)
46. Seror J, "Anti-TPO antibodies diffusion through the placental barrier during pregnancy", PLoS One, 9(1), pp.e84647~ (2014)
47. Duntas LH, "Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis", Eur J Endocrinol, 148(4), pp.389~393 (2003)
48. Gartner R, "Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations", J Clin Endocrinol Metab, 87(4), pp.1687~1691 (2002)
49. Mazokopakis EE, "Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis", Thyroid, 17(7), pp.609~612 (2007)
50. Fan Y, "Selenium supplementation for autoimmune thyroiditis : a systematic review and meta-analysis", Int J Endocrinol, 2014, pp.904573~ (2014)
51. Karanikas G, "No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis", Thyroid, 18(1), pp.7~12 (2008)
52. Negro R, "The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies", J Clin Endocrinol Metab, 92(4), pp.1263~1268 (2007)
53. Mao J, "Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency", Eur J Nutr, 55(1), pp.55~61 (2016)
54. Mantovani G, "Selenium supplementation in the management of thyroid autoimmunity during pregnancy : results of the"SERENA study", a randomized, double-blind, placebo-controlled trial", Endocrine, 66(3), pp.542~550 (2019)
55. Stranges S, "Effects of long-term selenium supplementation on the incidence of type 2 diabetes : a randomized trial", Ann Intern Med, 147(4), pp.217~223 (2007)
56. Wilcox AJ, "Incidence of early loss of pregnancy", N Engl J Med, 319(4), pp.189~194 (1988)
57. Ellish NJ, "A prospective study of early pregnancy loss", Hum Reprod, 11(2), pp.406~412 (1996)
58. Toth B, "Recurrent miscarriage : current concepts in diagnosis and treatment", J Reprod Immunol, 85(1), pp.25~32 (2010)
59. Dudley DJ, "Diabetic-associated stillbirth : incidence, pathophysiology, and prevention", Clin Perinatol, 34(4), pp.611~626 (2007)
60. De Vivo A, "Thyroid function in women found to have early pregnancy loss", Thyroid, 20(6), pp.633~637 (2010)
61. Casey BM, "Subclinical hyperthyroidism and pregnancy outcomes", Obstet Gynecol, 107(2 Pt 1), pp.337~341 (2006)
62. Stagnaro-Green A, "Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies", JAMA, 264(11), pp.1422~1425 (1990)
63. Iijima T, "Effects of autoantibodies on the course of pregnancy and fetal growth", Obstet Gynecol, 90(3), pp.364~369 (1997)
64. Glinoer D, "Pregnancy in patients with mild thyroid abnormalities : maternal and neonatal repercussions", J Clin Endocrinol Metab, 73(2), pp.421~427 (1991)
65. Sezer K, "Impact of first trimester and postpartum period thyroid autoantibodies on abortus incidence in Turkish pregnant women", Gynecol Endocrinol, 25(6), pp.387~391 (2009)
66. Chen L, "Thyroid autoimmunity and miscarriage : a meta-analysis", Clin Endocrinol(Oxf), 74(4), pp.513~519 (2011)
67. Thangaratinam S, "Association between thyroid autoantibodies and miscarriage and preterm birth : meta-analysis of evidence", BMJ, pp.d2616~ (2011)
68. Seungdamrong A, "Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women", Fertil Steril, 108(5), pp.843~850 (2017)
69. Imaizumi M, "Pregnancy and murine thyroiditis : thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies", Endocrinology, 142(2), pp.823~829 (2001)
70. Lee YL, "Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model", Fertil Steril, 91(5Suppl), pp.2104~2109 (2009)
71. Matalon ST, "The pathogenic role of anti-thyroglobulin antibody on pregnancy : evidence from an active immunization model in mice", Hum Reprod, 18(5), pp.1094~1099 (2003)
72. Twig G, "Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity", J Autoimmun, 38(2-3), pp.J275~81 (2012)
73. Lee RM, "Recurrent pregnancy loss : summary and clinical recommendations", Semin Reprod Med, 18(4), pp.433~440 (2000)
74. Baek KH, "Recurrent pregnancy loss : the key potential mechanisms", Trends Mol Med, 13(7), pp.310~317 (2007)
75. Iravani AT, "Thyroid autoimmunity and recurrent spontaneous abortion in Iran : a case-control study", Endocr Pract, 14(4), pp.458~464 (2008)
76. Kutteh WH, "Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction", Fertil Steril, 71(5), pp.843~848 (1999)
77. Lata K, "Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage : a case-control study", Endocr Connect, 2(2), pp.118~124 (2013)
78. Pratt DE, "The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy", Fertil Steril, 60(6), pp.1001~1005 (1993)
79. Bliddal S, "Thyroid peroxidase antibodies and prospective live birth rate : a cohort study of women with recurrent pregnancy loss", Thyroid, 29(10), pp.1465~1474 (2019)
80. van den Boogaard E, "Significance of(sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy : a systematic review", Hum Reprod Update, 17(5), pp.605~619 (2011)
81. Dong AC, "Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss : a systematic review and meta-analysis", Fertil Steril, 113(3), pp.587~600e1 (2020)
82. Esplin MS, "Thyroid autoantibodies are not associated with recurrent pregnancy loss", Am J Obstet Gynecol, 179(6 Pt 1), pp.1583~1586 (1998)
83. Rushworth FH, "Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies", Hum Reprod, 15(7), pp.1637~1639 (2000)
84. De Carolis C, "Anti-thyroid antibodies and antiphospholipid syndrome : evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters", Am J Reprod Immunol, 52(4), pp.263~266 (2004)
85. Kim NY, "Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures", Am J Reprod Immunol, 65(1), pp.78~87 (2011)
86. Lepoutre T, "Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases", Gynecol Obstet Invest, 74(4), pp.265~273 (2012)
87. Wang H, "Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer : a randomized clinical trial", JAMA, 318(22), pp.2190~2198 (2017)
88. Dhillon-Smith RK, "Levothyroxine in women with thyroid peroxidase antibodies before conception", N Engl J Med, 380(14), pp.1316~1325 (2019)
89. van Dijk MM, "Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss(T4LIFE trial) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial", Lancet Diabetes Endocrinol, 10(5), pp.322~329 (2022)
90. Negro R, "Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody-positive women with TSH less than 2. 5 mIU", L, 2016, pp.101(10), 3685~3690
91. Nazarpour S, "Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease", Eur J Endocrinol, 176(2), pp.253~265 (2017)
92. Lau L, "Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes : a systematic review and meta-analysis of randomised controlled trials", BMJ Open, 11(2), pp.e043751~ (2021)
93. Mathews TJ, "Infant mortality statistics from the 2002 period:linked birth", infant death data set, 2004, pp.53(10), 1~29
94. Petrou S, "The economic consequences of preterm birth during the first 10 years of life", BJOG, 112(Suppl 1), pp.10~15 (2005)
95. Goldenberg RL, "Epidemiology and causes of preterm birth", Lancet, 371(9606), pp.75~84 (2008)
96. Ghafoor F, "Role of thyroid peroxidase antibodies in the outcome of pregnancy", J Coll Physicians Surg Pak, 16(7), pp.468~471 (2006)
97. Haddow JE, "Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery", Obstet Gynecol, 116(1), pp.58~62 (2010)
98. Korevaar TI, "Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery : the generation R study", J Clin Endocrinol Metab, 98(11), pp.4382~4390 (2013)
99. Mannisto T, "Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies : a prospective population-based cohort study", J Clin Endocrinol Metab, 94(3), pp.772~779 (2009)
100. Plowden TC, "Thyroid-stimulating hormone, antithyroid antibodies, and pregnancy outcomes", Am J Obstet Gynecol, 217(6), pp.697 e1~697 e7 (2017)
101. Negro R, "Thyroid autoimmunity and pre-term delivery : brief review and meta-analysis", J Endocrinol Invest, 34(2), pp.155~158 (2011)
102. He X, "Thyroid antibodies and risk of preterm delivery : a meta-analysis of prospective cohort studies", Eur J Endocrinol, 167(4), pp.455~464 (2012)
103. Korevaar TIM, "Dose dependency and a functional cutoff for TPO-antibody positivity during pregnancy", J Clin Endocrinol Metab, 103(2), pp.778~789 (2018)
104. Karakosta P, "Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes", J Clin Endocrinol Metab, 97(12), pp.4464~4472 (2012)
105. Kumru P, "Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk population", Arch Gynecol Obstet, 291(5), pp.1047~1054 (2015)
106. Han Y, "Impact of maternal thyroid autoantibodies positivity on the risk of early term birth : Ma'anshan birth cohort study", Endocrine, 60(2), pp.329~338 (2018)
107. Consortium on Thyroid, "Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth : a systematic review and meta-analysis", JAMA, 322(7), pp.632~641 (2019)
108. Negro R, "Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes", J Clin Endocrinol Metab, 96(6), pp.E920~E924 (2011)
109. Groer MW, "Positive thyroid peroxidase antibody titer is associated with dysphoric moods during pregnancy and postpartum", J Obstet Gynecol Neonatal Nurs, 42(1), pp.E26~E32 (2013)
110. Kuijpens JL, "Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum", Eur J Endocrinol, 145(5), pp.579~584 (2001)
111. Li Y, "Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30months", Clin Endocrinol(Oxf), 72(6), pp.825~829 (2010)
112. Williams FL, "Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5. 5 years", J Clin Endocrinol Metab, 98(2), pp.829~838 (2013)
113. Wasserman EE, "Childhood IQ, hearing loss, and maternal thyroid autoimmunity in the Baltimore collaborative perinatal project", Pediatr Res, 72(5), pp.525~530 (2012)
114. Derakhshan A, "The association of maternal thyroid autoimmunity during pregnancy with Child IQ", J Clin Endocrinol Metab, 103(10), pp.3729~3736 (2018)
115. Ghassabian A, "Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit", hyperactivity problems in children : the generation R Study, 2012, pp.22(2), 178~186
116. Brown AS, "Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort", Prog Neuropsychopharmacol Biol Psychiatry, 57, pp.86~92 (2015)
117. Heikkinen AL, "Maternal thyroid antibodies associates with cardiometabolic risk factors in children at the age of 16", J Clin Endocrinol Metab, 102(11), pp.4184~4190 (2017)
118. Kent NL, "Is the link between elevated TSH and gestational diabetes mellitus dependant on diagnostic criteria and thyroid antibody status : a systematic review and meta-analysis", Endocrine, 74(1), pp.38~49 (2021)
119. Yang Y, "Maternal thyroid dysfunction and gestational anemia risk : meta-analysis and new data", Front Endocrinol(Lausanne), 11, pp.201~ (2020)
120. Krassas GE, "Menstrual disturbances in thyrotoxicosis", Clin Endocrinol(Oxf), 40(5), pp.641~644 (1994)
121. Krassas GE, "Disturbances of menstruation in hypothyroidism", Clin Endocrinol(Oxf), 50(5), pp.655~659 (1999)
122. Poppe K, "Thyroid dysfunction and autoimmunity in infertile women", Thyroid, 12(11), pp.997~1001 (2002)
123. Grassi G, "Thyroid autoimmunity and infertility", Gynecol Endocrinol, 15(5), pp.389~396 (2001)
124. Quintino-Moro A, "High prevalence of infertility among women with Graves' disease and Hashimoto's thyroiditis", Int J Endocrinol, 2014, pp.982705~ (2014)
125. Kucukler FK, "Evaluation of ovarian reserve in women with overt or subclinical hypothyroidism", Arch Med Sci, 14(3), pp.521~526 (2018)
126. Lincoln SR, "Screening for hypothyroidism in infertile women", J Reprod Med, 44(5), pp.455~457 (1999)
127. Abalovich M, "Subclinical hypothyroidism and thyroid autoimmunity in women with infertility", Gynecol Endocrinol, 23(5), pp.279~283 (2007)
128. Arojoki M, "Hypothyroidism among infertile women in Finland", Gynecol Endocrinol, 14(2), pp.127~131 (2000)
129. Rao M, "Subclinical hypothyroidism is associated with lower ovarian reserve in women aged 35 years or older", Thyroid, 30(1), pp.95~105 (2020)
130. Birjandi B, "The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study : Tehran thyroid study(TTS)", BMC Endocr Disord, 21(1), pp.108~ (2021)
131. Verma I, "Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility", Int J Appl Basic Med Res, 2(1), pp.17~19 (2012)
132. Yoshioka W, "Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility", Endocr J, 62(1), pp.87~92 (2015)
133. Monteleone P, "Female infertility related to thyroid autoimmunity : the ovarian follicle hypothesis", Am J Reprod Immunol, 66(2), pp.108~114 (2011)
134. Ott J, "Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome", Fertil Steril, 94(7), pp.2895~2897 (2010)
135. Karmon AE, "Preconceptional thyroid-stimulating hormone levels and outcomes of intrauterine insemination among euthyroid infertile women", Fertil Steril, 103(1), pp.258~263 e1 (2015)
136. Pekcan MK, "Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women", JBRA Assist Reprod, 23(2), pp.137~142 (2019)
137. Fumarola A, "Thyroid function in infertile patients undergoing assisted reproduction", Am J Reprod Immunol, 70(4), pp.336~341 (2013)
138. Baker VL, "Correlation of thyroid stimulating hormone(TSH)level with pregnancy outcome in women undergoing in vitro fertilization", Am J Obstet Gynecol, 194(6), pp.1668~1674 (2006)
139. Reh A, "What is a normal thyroidstimulating hormone(TSH)level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization", Fertil Steril, 94(7), pp.2920~2922 (2010)
140. Weghofer A, "The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve : a case-control study", Reprod Biol Endocrinol, 13, pp.43~ (2015)
141. Aghahosseini M, "Effects of thyroid stimulating hormone(TSH)level on clinical pregnancy rate via in vitro fertilization(IVF)procedure", Med J Islam Repub Iran, 28, pp.46~ (2014)
142. Green KA, "Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality", J Assist Reprod Genet, 32(10), pp.1469~1476 (2015)
143. So S, "Effect of moderately increased thyroid-stimulating hormone levels and presence of thyroid antibodies on pregnancy among infertile women", Reprod Med Biol, 19(1), pp.82~88 (2020)
144. Karakis LS, "Impact of preconceptional serum thyroid stimulating hormone values ranging between 2. 5 and 4. 5 mIU", L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility, 2021, pp.21(1), 162~
145. Chai J, "Live birth rates following in vitro fertilization in women with thyroid autoimmunity and", or subclinical hypothyroidism, 2014, pp.80(1), 122~127
146. Abdel Rahman AH, "Improved in vitro fertilization outcomes after treatment of subclinical hypothyroidism in infertile women", Endocr Pract, 16(5), pp.792~797 (2010)
147. Kim CH, "Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization", intracytoplasmic sperm injection, 2011, pp.95(5), 1650~1654
148. Velkeniers B, "Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies : systematic review and meta-analysis of RCTs", Hum Reprod Update, 19(3), pp.251~258 (2013)
149. Arora H, "Positive effects of thyroid replacement therapy on assisted reproductive technology outcomes in women with subclinical hypothyroidism with positive thyroid peroxidase autoantibodies", F S Rep, 3(1), pp.32~38 (2022)
150. Jatzko B, "The impact of thyroid function on intrauterine insemination outcome--a retrospective analysis", Reprod Biol Endocrinol, 12, pp.28~ (2014)
151. Alexander EK, "2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum", Thyroid, 27(3), pp.315~389 (2017)
152. Poppe K, "2021 European Thyroid Association guideline on thyroid disorders prior to and during assisted reproduction", Eur Thyroid J, 9(6), pp.281~295 (2021)
153. Scoccia B, "In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders", Thyroid, 22(6), pp.631~636 (2012)
154. Busnelli A, "In vitro fertilization outcomes in treated hypothyroidism", Thyroid, 23(10), pp.1319~1325 (2013)
155. Pelliccione F, "Levothyroxine supplementation on assisted reproduction technology(ART)outcomes in women with subtle hypothyroidism : a retrospective study", Gynecol Endocrinol, 34(12), pp.1053~1058 (2018)
156. Zhong YP, "Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer", Int J Med Sci, 9(2), pp.121~125 (2012)
157. Tan S, "Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women", Eur J Endocrinol, 170(4), pp.495~500 (2014)
158. Lukaszuk K, "The impact of the presence of antithyroid antibodies on pregnancy outcome following intracytoplasmatic sperm injection-ICSI and embryo transfer in women with normal thyreotropine levels", J Endocrinol Invest, 38(12), pp.1335~1343 (2015)
159. Karacan M, "Effect of antithyroid antibodies on ICSI outcome in antiphospholipid antibody-negative euthyroid women", Reprod Biomed Online, 27(4), pp.376~380 (2013)
160. Toulis KA, "Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF : a meta-analysis", Eur J Endocrinol, 162(4), pp.643~652 (2010)
161. Inagaki Y, "The influence of thyroid autoimmunity on pregnancy outcome in infertile women : a prospective study", Endocr J, 67(8), pp.859~868 (2020)
162. Negro R, "Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies : a prospective study", Hum Reprod, 20(6), pp.1529~1533 (2005)
163. Revelli A, "A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies : effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments", Reprod Biol Endocrinol, 7, pp.137~ (2009)
164. Poppe K, "Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome", Fertil Steril, 96(1), pp.241~245 (2011)
165. Poppe K, "Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity", J Clin Endocrinol Metab, 89(8), pp.3808~3812 (2004)
166. Mintziori G, "Thyroid function during ovarian stimulation : a systematic review", Fertil Steril, 96(3), pp.780~785 (2011)
167. Muller AF, "Decrease of free thyroxine levels after controlled ovarian hyperstimulation", J Clin Endocrinol Metab, 85(2), pp.545~548 (2000)
168. Poppe K, "Thyroid function after assisted reproductive technology in women free of thyroid disease", Fertil Steril, 83(6), pp.1753~1757 (2005)
169. Gracia CR, "Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization", Fertil Steril, 97(3), pp.585~591 (2012)
170. Reinblatt S, "Thyroid stimulating hormone levels rise after assisted reproductive technology", J Assist Reprod Genet, 30(10), pp.1347~1352 (2013)
171. Benaglia L, "Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization", Eur J Obstet Gynecol Reprod Biol, 173, pp.53~57 (2014)
172. Busnelli A, "Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients", Thyroid, 24(11), pp.1650~1655 (2014)
173. Haddow JE, "Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child", N Engl J Med, 341(8), pp.549~555 (1999)
174. van den Boogaard E, "Significance of(sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy : a systematic review", Hum Reprod Update, 22(4), pp.532~533 (2016)
175. Turunen S, "Indications for intensive care unit treatment among neonates born to mothers with thyroid disease : a population-based cohort study", Acta Obstet Gynecol Scand, 101(10), pp.1093~1101 (2022)
176. Abalovich M, "Overt and subclinical hypothyroidism complicating pregnancy", Thyroid, 12(1), pp.63~68 (2002)
177. Leung AS, "Perinatal outcome in hypothyroid pregnancies", Obstet Gynecol, 81(3), pp.349~353 (1993)
178. Allan WC, "Maternal thyroid deficiency and pregnancy complications : implications for population screening", J Med Screen, 7(3), pp.127~130 (2000)
179. Negro R, "Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy", J Clin Endocrinol Metab, 95(4), pp.1699~1707 (2010)
180. Negro R, "Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2. 5 and 5. 0 in the first trimester of pregnancy", J Clin Endocrinol Metab, 95(9), pp.E44~8 (2010)
181. Casey BM, "Subclinical hypothyroidism and pregnancy outcomes", Obstet Gynecol, 105(2), pp.239~245 (2005)
182. Benhadi N, "Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death", Eur J Endocrinol, 160(6), pp.985~991 (2009)
183. Ashoor G, "Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death", Thyroid, 20(9), pp.989~993 (2010)
184. Cleary-Goldman J, "Maternal thyroid hypofunction and pregnancy outcome", Obstet Gynecol, 112(1), pp.85~92 (2008)
185. Mannisto T, "Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life", J Clin Endocrinol Metab, 95(3), pp.1084~1094 (2010)
186. Medici M, "Thyroid function in pregnancy : what is normal?", Clin Chem, 61(5), pp.704~713 (2015)
187. Toloza FJK, "Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia : a systematic review and individual-participant data meta-analysis", Lancet Diabetes Endocrinol, 10(4), pp.243~252 (2022)
188. Wilson KL, "Subclinical thyroid disease and the incidence of hypertension in pregnancy", Obstet Gynecol, 119(2 Pt 1), pp.315~320 (2012)
189. Panagiotou G, "Late offspring effects of antenatal thyroid screening", Br Med Bull, 143(1), pp.16~29 (2022)
190. Lazarus JH, "Antenatal thyroid screening and childhood cognitive function", N Engl J Med, 366(6), pp.493~501 (2012)
191. Casey BM, "Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy", N Engl J Med, 376(9), pp.815~825 (2017)
192. Downing S, "Severe maternal hypothyroidism corrected prior to the third trimester is associated with normal cognitive outcome in the offspring", Thyroid, 22(6), pp.625~630 (2012)
193. Momotani N, "Neurodevelopment in children born to hypothyroid mothers restored to normal thyroxine(T(4))concentration by late pregnancy in Japan : no apparent influence of maternal T(4)deficiency", J Clin Endocrinol Metab, 97(4), pp.1104~1108 (2012)
194. Liu H, "Maternal hypothyroidism during early pregnancy and intellectual development of the progeny", Arch Intern Med, 154(7), pp.785~787 (1994)
195. Pop VJ, "Maternal hypothyroxinaemia during early pregnancy and subsequent child development : a 3-year follow-up study", Clin Endocrinol(Oxf), 59(3), pp.282~288 (2003)
196. Sahu MT, "Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome", Arch Gynecol Obstet, 281(2), pp.215~220 (2010)
197. Su PY, "Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development : a prospective population-based cohort study in China", J Clin Endocrinol Metab, 96(10), pp.3234~3241 (2011)
198. Henrichs J, "Maternal hypothyroxinemia and effects on cognitive functioning in childhood : how and why?", Clin Endocrinol(Oxf), 79(2), pp.152~162 (2013)
199. Medici M, "Maternal thyroid hormone parameters during early pregnancy and birth weight : the generation R study", J Clin Endocrinol Metab, 98(1), pp.59~66 (2013)
200. Nazarpour S, "Effects of isolated maternal hypothyroxinemia on adverse pregnancy outcomes", Arch Gynecol Obstet, 305(4), pp.903~911 (2022)
201. Avramovska M, "Isolated maternal hypothyroxinemia and its perinatal outcome in North Macedonia", Acta Clin Croat, 60(2), pp.246~253 (2021)
202. Chen L, "Insignificant effect of isolated hypothyroxinemia on pregnancy outcomes during the first and second trimester of pregnancy", Front Endocrinol(Lausanne), 11, pp.528146~ (2020)
203. Gong X, "The impact of isolated maternal hypothyroxinemia during the first and second trimester of gestation on pregnancy outcomes : an intervention and prospective cohort study in China", J Endocrinol Invest, 42(5), pp.599~607 (2019)
204. Hamm MP, "The impact of isolated maternal hypothyroxinemia on perinatal morbidity", J Obstet Gynaecol Can, 31(11), pp.1015~1021 (2009)
205. Casey BM, "Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy", Obstet Gynecol, 109(5), pp.1129~1135 (2007)
206. Turunen S, "Pregnancy and perinatal outcome among hypothyroid mothers : a populationbased cohort study", Thyroid, 29(1), pp.135~141 (2019)
207. Alexander EK, "Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism", N Engl J Med, 351(3), pp.241~249 (2004)
208. Mandel SJ, "Increased need for thyroxine during pregnancy in women with primary hypothyroidism", N Engl J Med, 323(2), pp.91~96 (1990)
209. Kaplan MM, "Monitoring thyroxine treatment during pregnancy", Thyroid, 2(2), pp.147~152 (1992)
210. Loh JA, "The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism", Thyroid, 19(3), pp.269~275 (2009)
211. Yassa L, "Thyroid hormone early adjustment in pregnancy(the THERAPY)trial", J Clin Endocrinol Metab, 95(7), pp.3234~3241 (2010)
212. Rotondi M, "Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy", Eur J Endocrinol, 151(6), pp.695~700 (2004)
213. Abalovich M, "The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism", Thyroid, 20(10), pp.1175~1178 (2010)
214. Galofré JC, "Increased postpartum thyroxine replacement in Hashimoto's thyroiditis", Thyroid, 20(8), pp.901~908 (2010)
215. Li N, "Postpartum follow-up of patients with subclinical hypothyroidism during pregnancy", Thyroid, 30(11), pp.1566~1573 (2020)
216. Braverman LE, "Werner & Ingbar's the thyroid: a fundamental and clinical text", pp.453~455 (2005), Lippincott, Williams & Wilkins
217. Cooper DS, "Hyperthyroidism in pregnancy", Lancet Diabetes Endocrinol, 1(3), pp.238~249 (2013)
218. Dong AC, "Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy : a systematic review and meta-analysis", Thyroid, 29(2), pp.278~289 (2019)
219. Fan J, "Persistency of thyroid dysfunction from early to late pregnancy", Thyroid, 29(10), pp.1475~1484 (2019)
220. Kinomoto-Kondo S, "The effects of gestational transient thyrotoxicosis on the perinatal outcomes : a case-control study", Arch Gynecol Obstet, 295(1), pp.87~93 (2017)
221. Fraenkel M, "Low thyroid-stimulating hormone and its persistence beyond the first trimester of pregnancy", Int J Gynaecol Obstet, 142(3), pp.270~276 (2018)
222. Tan JY, "Transient hyperthyroidism of hyperemesis gravidarum", BJOG, 109(6), pp.683~688 (2002)
223. Niebyl JR, "Clinical practice. Nausea and vomiting in pregnancy", N Engl J Med, 363(16), pp.1544~1550 (2010)
224. Verberg MF, "Hyperemesis gravidarum, a literature review", Hum Reprod Update, 11(5), pp.527~539 (2005)
225. Grun JP, "The thyrotrophic role of human chorionic gonadotrophin(hCG)in the early stages of twin(versus single)pregnancies", Clin Endocrinol(Oxf), 46(6), pp.719~725 (1997)
226. Hershman JM, "Human chorionic gonadotropin and the thyroid : hyperemesis gravidarum and trophoblastic tumors", Thyroid, 9(7), pp.653~657 (1999)
227. Rodien P, "Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin", N Engl J Med, 339(25), pp.1823~1826 (1998)
228. Goodwin TM, "Transient hyperthyroidism and hyperemesis gravidarum : clinical aspects", Am J Obstet Gynecol, 167(3), pp.648~652 (1992)
229. Bouillon R, "Thyroid function in patients with hyperemesis gravidarum", Am J Obstet Gynecol, 143(8), pp.922~926 (1982)
230. Laurberg P, "Management of Graves' hyperthyroidism in pregnancy : focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy", Eur J Endocrinol, 160(1), pp.1~8 (2009)
231. de Jong JA, "High failure rates after(131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover", Clin Nucl Med, 38(6), pp.401~406 (2013)
232. Schneider DF, "Failure of radioactive iodine in the treatment of hyperthyroidism", Ann Surg Oncol, 21(13), pp.4174~4180 (2014)
233. Millar LK, "Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism", Obstet Gynecol, 84(6), pp.946~949 (1994)
234. Papendieck P, "Thyroid disorders of neonates born to mothers with Graves'disease", J Pediatr Endocrinol Metab, 22(6), pp.547~553 (2009)
235. Phoojaroenchanachai M, "Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight", Clin Endocrinol(Oxf), 54(3), pp.365~370 (2001)
236. Sheffield JS, "Thyrotoxicosis and heart failure that complicate pregnancy", Am J Obstet Gynecol, 190(1), pp.211~217 (2004)
237. Turunen S, "Maternal hyperthyroidism and pregnancy outcomes : a population-based cohort study", Clin Endocrinol(Oxf), 93(6), pp.721~728 (2020)
238. Andersen SL, "Maternal thyroid function in early pregnancy and child neurodevelopmental disorders : a Danish nationwide case-cohort study", Thyroid, 28(4), pp.537~546 (2018)
239. Levie D, "Maternal thyroid function in early pregnancy and child attention-deficit hyperactivity disorder : an individual-participant meta-analysis", Thyroid, 29(9), pp.1316~1326 (2019)
240. Ge GM, "Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring : a systematic review and meta-analysis", J Clin Endocrinol Metab, 105(12), pp.dgaa555~ (2020)
241. Mandel SJ, "The use of antithyroid drugs in pregnancy and lactation", J Clin Endocrinol Metab, 86(6), pp.2354~2359 (2001)
242. Andersen SL, "Antithyroid drug side effects in the population and in pregnancy", J Clin Endocrinol Metab, 101(4), pp.1606~1614 (2016)
243. Bahn RS, "The role of propylthiouracil in the management of Graves' disease in adults : report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration", Thyroid, 19(7), pp.673~674 (2009)
244. Rivkees SA, "Propylthiouracil(PTU)hepatoxicity in children and recommendations for discontinuation of use", Int J Pediatr Endocrinol, 2009, pp.132041~ (2009)
245. Clementi M, "Methimazole embryopathy : delineation of the phenotype", Am J Med Genet, 83(1), pp.43~46 (1999)
246. Clementi M, "Treatment of hyperthyroidism in pregnancy and birth defects", J Clin Endocrinol Metab, 95(11), pp.E337~41 (2010)
247. Barbero P, "Choanal atresia associated with maternal hyperthyroidism treated with methimazole : a case-control study", Am J Med Genet A, 146A(18), pp.2390~2395 (2008)
248. Andersen SL, "Birth defects after early pregnancy use of antithyroid drugs : a Danish nationwide study", J Clin Endocrinol Metab, 98(11), pp.4373~4381 (2013)
249. Seo GH, "Antithyroid drugs and congenital malformations : a nationwide Korean cohort study", Ann Intern Med, 168(6), pp.405~413 (2018)
250. Miao Y, "Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes : a meta-analysis", PLoS One, 17(3), pp.e0265085~ (2022)
251. Morales DR, "Antithyroid drug use during pregnancy and the risk of birth defects in offspring : systematic review and meta-analysis of observational studies with methodological considerations", Br J Clin Pharmacol, 87(10), pp.3890~3900 (2021)
252. Song R, "Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations : a meta-analysis", PLoS One, 12(7), pp.e0180108~ (2017)
253. Yu W, "Side effects of PTU and MMI in the treatment of hyperthyroidism : a systematic review and meta-analysis", Endocr Pract, 26(2), pp.207~217 (2020)
254. Laurberg P, "Therapy of endocrine disease : antithyroid drug use in early pregnancy and birth defects : time windows of relative safety and high risk?", Eur J Endocrinol, 171(1), pp.R13~20 (2014)
255. Andersen SL, "Severity of birth defects after propylthiouracil exposure in early pregnancy", Thyroid, 24(10), pp.1533~1540 (2014)
256. Laurberg P, "Relapse following antithyroid drug therapy for Graves' hyperthyroidism", Curr Opin Endocrinol Diabetes Obes, 21(5), pp.415~421 (2014)
257. Cooper DS, "Antithyroid drugs in the management of patients with Graves' disease : an evidence-based approach to therapeutic controversies", J Clin Endocrinol Metab, 88(8), pp.3474~3481 (2003)
258. Rubin PC, "Current concepts : beta-blockers in pregnancy", N Engl J Med, 305(22), pp.1323~1326 (1981)
259. Sherif IH, "Treatment of hyperthyroidism in pregnancy", Acta Obstet Gynecol Scand, 70(6), pp.461~463 (1991)
260. Abraham P, "Antithyroid drug regimen for treating Graves' hyperthyroidism", Cochrane Database Syst Rev, 2010(1), pp.CD003420~ (2010)
261. Patil-Sisodia K, "Graves hyperthyroidism and pregnancy : a clinical update", Endocr Pract, 16(1), pp.118~129 (2010)
262. Ochoa-Maya MR, "Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism", Thyroid, 9(11), pp.1111~1114 (1999)
263. Hamburger JI, "Diagnosis and management of Graves' disease in pregnancy", Thyroid, 2(3), pp.219~224 (1992)
264. Amino N, "Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease", J Clin Endocrinol Metab, 55(1), pp.108~112 (1982)
265. Laurberg P, "Guidelines for TSH-receptor antibody measurements in pregnancy : results of an evidence-based symposium organized by the European Thyroid Association", Eur J Endocrinol, 139(6), pp.584~586 (1998)
266. Momotani N, "Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy", J Clin Endocrinol Metab, 75(3), pp.738~744 (1992)
267. Zwaveling-Soonawala N, "Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease : an effect of maternally derived thyrotrophin receptor antibodies?", Thyroid, 19(6), pp.661~662 (2009)
268. Kempers MJ, "Central congenital hypothyroidism due to gestational hyperthyroidism : detection where prevention failed", J Clin Endocrinol Metab, 88(12), pp.5851~5857 (2003)
269. Gruner C, "Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature", Fetal Diagn Ther, 16(1), pp.47~51 (2001)
270. Peleg D, "The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis", Obstet Gynecol, 99(6), pp.1040~1043 (2002)
271. Luton D, "Management of Graves' disease during pregnancy : the key role of fetal thyroid gland monitoring", J Clin Endocrinol Metab, 90(11), pp.6093~6098 (2005)
272. Zimmerman D, "Fetal and neonatal hyperthyroidism", Thyroid, 9(7), pp.727~733 (1999)
273. Yoshihara A, "Incidence of neonatal hyperthyroidism among newborns of Graves' disease patients treated with radioiodine therapy", Thyroid, 29(1), pp.128~134 (2019)
274. van Dijk MM, "Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis : a systematic review", Thyroid, 28(2), pp.257~264 (2018)
275. Rotondi M, "The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy", J Clin Endocrinol Metab, 93(10), pp.3985~3988 (2008)
276. Benhaim Rochester D, "Increased risk of Graves'disease after pregnancy", Thyroid, 15(11), pp.1287~1290 (2005)
277. Rotondi M, "The post partum period and the onset of Graves' disease : an overestimated risk factor", Eur J Endocrinol, 159(2), pp.161~165 (2008)
278. Amino N, "High prevalence of transient post-partum thyrotoxicosis and hypothyroidism", N Engl J Med, 306(14), pp.849~852 (1982)
279. Qaseem A, "The development of clinical practice guidelines and guidance statements of the American College of Physicians : summary of methods", Ann Intern Med, 153(3), pp.194~199 (2010)
280. Stagnaro-Green A, "Approach to the patient with postpartum thyroiditis", J Clin Endocrinol Metab, 97(2), pp.334~342 (2012)
281. Stagnaro-Green A, "Clinical review 152 : postpartum thyroiditis", J Clin Endocrinol Metab, 87(9), pp.4042~4047 (2002)
282. Stagnaro-Green A, "High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in Southern Italy", J Clin Endocrinol Metab, 96(3), pp.652~657 (2011)
283. Benvenga S, "Relatively high rate of postpartum thyroiditis in the Straits of Messina area. Predictivity of both postpartum thyroiditis and permanent hypothyroidism by performing, in the first trimester of gestation, thyroid ultrasonography and measurement of serum thyroperoxidase and thyroglobulin autoantibodies", J Clin Transl Endocrinol, 15, pp.12~18 (2019)
284. Muller AF, "Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age : recent insights and consequences for antenatal and postnatal care", Endocr Rev, 22(5), pp.605~630 (2001)
285. Kuijpens JL, "Cell-mediated immunity and postpartum thyroid dysfunction : a possibility for the prediction of disease?", J Clin Endocrinol Metab, 83(6), pp.1959~1966 (1998)
286. Stagnaro-Green A, "A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy : evidence of a T-cell etiology for postpartum thyroid dysfunction", J Clin Endocrinol Metab, 74(3), pp.645~653 (1992)
287. Smallridge RC, "Postpartum thyroid disease. A model of immunologic dysfunction", Clin Appl Immunol Rev, 1, pp.89~103 (2000)
288. Ide A, "Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow", Thyroid, 24(6), pp.1027~1031 (2014)
289. Nicholson WK, "Prevalence of postpartum thyroid dysfunction : a quantitative review", Thyroid, 16(6), pp.573~582 (2006)
290. Gerstein HC, "Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus", Ann Intern Med, 118(6), pp.419~423 (1993)
291. Alvarez-Marfany M, "Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus", J Clin Endocrinol Metab, 79(1), pp.10~16 (1994)
292. Elefsiniotis IS, "Post-partum thyroiditis in women with chronic viral hepatitis", J Clin Virol, 41(4), pp.318~319 (2008)
293. Stagnaro-Green A, "Thyroid disease in pregnant women with systemic lupus erythematosus : increased preterm delivery", Lupus, 20(7), pp.690~699 (2011)
294. Tagami T, "The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease", Thyroid, 17(8), pp.767~772 (2007)
295. Manetti L, "Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis : a nested case-control study", Eur J Endocrinol, 159(6), pp.805~809 (2008)
296. Lazarus JH, "Clinical aspects of recurrent postpartum thyroiditis", Br J Gen Pract, 47(418), pp.305~308 (1997)
297. Caixas A, "Postpartum thyroiditis in women with hypothyroidism antedating pregnancy?", J Clin Endocrinol Metab, 84(11), pp.4000~4005 (1999)
298. Marqusee E, "Thyroiditis after pregnancy loss", J Clin Endocrinol Metab, 82(8), pp.2455~2457 (1997)
299. Walfish PG, "Prevalence and characteristics of post-partum thyroid dysfunction : results of a survey from Toronto, Canada", J Endocrinol Invest, 15(4), pp.265~272 (1992)
300. Hayslip CC, "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction", Am J Obstet Gynecol, 159(1), pp.203~209 (1988)
301. Lazarus JH, "Clinical manifestations of postpartum thyroid disease", Thyroid, 9(7), pp.685~689 (1999)
302. Pop VJ, "Postpartum thyroid dysfunction and depression in an unselected population", N Engl J Med, 324(25), pp.1815~1816 (1991)
303. Le Donne M, "Early pospartum alexithymia and risk for depression : relationship with serum thyrotropin, free thyroid hormones and thyroid autoantibodies", Psychoneuroendocrinology, 37(4), pp.519~533 (2012)
304. Bergink V, "Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period : a Danish nationwide register-based cohort study", Psychol Med, 48(8), pp.1291~1298 (2018)
305. Lucas A, "Postpartum thyroid dysfunction and postpartum depression : are they two linked disorders?", Clin Endocrinol(Oxf), 55(6), pp.809~814 (2001)
306. Pop VJ, "Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression", Acta Endocrinol(Copenh), 129(1), pp.26~30 (1993)
307. Harris B, "Association between postpartum thyroid dysfunction and thyroid antibodies and depression", BMJ, 305(6846), pp.152~156 (1992)
308. Lazarus JH, "The clinical spectrum of postpartum thyroid disease", QJM, 89(6), pp.429~435 (1996)
309. Konstantakou P, "Associations of thyroid hormones profile during normal pregnancy and postpartum with anxiety, depression, and obsessive", compulsive disorder scores in euthyroid women, 2021, pp.15, 663348~
310. Wesseloo R, "Thyroid peroxidase antibodies during early gestation and the subsequent risk of first-onset postpartum depression : a prospective cohort study", J Affect Disord, 225, pp.399~403 (2018)
311. Minaldi E, "Thyroid autoimmunity and risk of post-partum depression : a systematic review and metaanalysis of longitudinal studies", J Endocrinol Invest, 43(3), pp.271~277 (2020)
312. Harris B, "Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women", Br J Psychiatry, 180, pp.327~330 (2002)
313. Costantine MM, "Effect of thyroxine therapy on depressive symptoms among women with subclinical hypothyroidism", Obstet Gynecol, 135(4), pp.812~820 (2020)
314. Fung HY, "Postpartum thyroid dysfunction in Mid Glamorgan", Br Med J(Clin Res Ed), 296(6617), pp.241~244 (1988)
315. Rasmussen NG, "Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis", Acta Endocrinol(Copenh), 123(4), pp.395~401 (1990)
316. Azizi F, "The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis", Eur J Endocrinol, 153(3), pp.367~371 (2005)
317. Nohr SB, "Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency : is iodine supplementation safe?", J Clin Endocrinol Metab, 85(9), pp.3191~3198 (2000)
318. Gao X, "Postpartum thyroid dysfunction in women with known and newly diagnosed hypothyroidism in early pregnancy", Front Endocrinol(Lausanne), 12, pp.746329~ (2021)
319. Kampe O, "Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis", J Clin Endocrinol Metab, 70(4), pp.1014~1018 (1990)
320. Eriksen KG, "Effects of an iodine-containing prenatal multiple micronutrient on maternal and infant iodine status and thyroid function : a randomized trial in the Gambia", Thyroid, 30(9), pp.1355~1365 (2020)
321. Mridha MK, "Daily consumption of lipid-based nutrient supplements containing 250 mug iodine does not increase urinary iodine concentrations in pregnant and postpartum women in Bangladesh", J Nutr, 147(8), pp.1586~1592 (2017)

관련 논문AI추천